Expert Rev Ophthalmol. 2008;3(3):311-323. The new and promising strategies for treating CNV include the use of drugs against VEGF, in particular isoform A, which is the most potent promoter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results